A Scandinavian economic behemoth, Novo Nordisk is the highest valued company in Europe at over $500 billion, which exceeds ...

If you said diabetes, you're right -- a new study finds diabetes costs $101 billion annually in diagnosis and treatment and ...

(HealthDay News) — The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded ... I’m quite alarmed by what we see in the U.S. now,” Novo Nordisk ...

Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...

Lars Fruergaard Jørgensen began his career at Novo Nordisk as an economist in the health care, economy, and planning ...

Ozempic, Mounjaro, Wegovy, Victoza and Trulicity are part of a class of ... consultation with a healthcare professional and ...

Lifecore now operates at less than 35% utilization, meaning that it can almost triple revenue with virtually no additional ...

The authorities of the Danish capital are launching the "Come to Us" campaign. Its goal is to attract educated U.S. citizens ...

Are you a print subscriber? Activate your account. By Garett Sloane - 3 min 8 sec ago By Ewan Larkin - 8 min 31 sec ago By ...

Unicef's representative in Pakistan issued a stark warning about the severe health risks posed by hazardous air quality in Punjab, impacting over 11 million children. The alarming pollution levels ...

Every earnings season has its share of outperformers, companies that report blowout quarters and raise their forecasts. The ...